ReviewJournal of diabetes research2018
Access to Hemoglobin A1c in Rural Africa: A Difficult Reality with Severe Consequences.
Review in Journal of diabetes research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- The impact of prolonged walking on fasting plasma glucose in type 2 diabetes: A randomised controlled crossover study.Diabetic medicine : a journal of the British Diabetic Association · 2025Trial
- Quality of life among adult patients living with diabetes in Rwanda: a cross-sectional study in outpatient clinics.BMJ open · 2021Trial
- Escalating diabetes prevalence in pakistan: a qualitative study of endocrinologists' perspectives on contributing factors, management barriers, and strategies.BMC endocrine disorders · 2026Article
- Barriers to effective management of type 2 diabetes mellitus in primary healthcare facilities.Journal of public health in Africa · 2025Article
- Comparing the effectiveness and cost-effectiveness of alternative type 2 diabetes monitoring intervals in resource limited settings.Health policy and planning · 2024Article
- Implementing HbA1c monitoring in sub-Saharan Africa: Lessons learnt from a pilot project in Mozambique.Public health in practice (Oxford, England) · 2024Article
- Evaluation of Red Blood Cell Indices for Prediction of Glycemic Control in People Living with Type 2 Diabetes.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024Article
- Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c.Nature medicine · 2023Article
- Accessibility and utilization of healthcare services among diabetic patients: Is diabetes a poor man's ailment?World journal of diabetes · 2023Review
- Impact of Lockdown Measures on Health Outcomes of Adults with Type 2 Diabetes Mellitus in Bangladesh.Healthcare (Basel, Switzerland) · 2023Article
- Article
- Factors Influencing the Utilization of Diabetes Complication Tests Under the COVID-19 Pandemic: Machine Learning Approach.Frontiers in endocrinology · 2022Article
- Prevalence and sociodemographic correlates of diabetes among adults in Namibia and South Africa.Journal of the National Medical Association · 2022Article
- Review
- Socioeconomic Factors Associated With Glycemic Measurement and Poor HbA1c Control in People With Type 2 Diabetes: The Global DISCOVER Study.Frontiers in endocrinology · 2022Observational
- The Role of the Integrated District Hospital Based Non Communicable Diseases' Clinics in Cardiovascular Disease Control: Preliminary Data from Rwanda.Diabetes, metabolic syndrome and obesity : targets and therapy · 2022Article
- Article
- Integrating health services for HIV infection, diabetes and hypertension in sub-Saharan Africa: a cohort study.BMJ open · 2021Article
- HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: the OPTIMAL observational multicenter study.BMJ open diabetes research & care · 2021Observational
- Serum fructosamine and glycemic status in the presence of the sickle cell mutation.Diabetes research and clinical practice · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sub-Saharan Africa (SSA) continues to have the highest diabetes-related mortality rate in the world. While there exists a multitude of health system barriers driving poor diabetes control, rural facilities particularly in SSA lack access to proper monitoring of glucose and other key biologic tests. At best, most of these diabetes patients receive random blood sugar readings only on the day of their clinic visit. This approach has very limited clinical value in determining dosage adjustments for narrow therapeutic index medications such as insulin. Furthermore, access to other blood tests and physical exam tools for detecting early signs of diabetes complications is limited. We propose that routine access to hemoglobin A1c (HbA1c) testing would not only allow for close monitoring of diabetes control but also provide critical data informing the population level risk for diabetes complications. However, implementing HbA1c testing does have its own barriers at rural facilities, including high costs, refrigeration requirements, and perceived discordance between HbA1c values and mean blood glucose levels for SSA patients. Fortunately, several pilots in rural SSA have illustrated feasibility of HbA1c testing. Further political will, price reduction, and context-specific research are needed. Increasing access to HbA1c testing is a critical step to combat the high diabetes-related mortality rates in rural SSA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.